NTH Share Price | Naturhouse Health SA Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Naturhouse Health SA with Similar Stocks

Pharma Mar SA

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Management Efficiency with a high ROE of 60.39%

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 22.81

Poor long term growth as Net Sales has grown by an annual rate of -6.11% and Operating profit at -8.51% over the last 5 years

With ROE of 65.53%, it has a Fair valuation with a 5.97 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 154 Million ()

P/E

9.00

Industry P/E

Dividend Yield

398.83%

Debt Equity

-0.73

Return on Equity

58.10%

Price to Book

8.69

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2022)

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

1.58%

6 Months

27.86%

1 Year

43.98%

2 Years

54.35%

3 Years

51.18%

4 Years

41.99%

5 Years

51.18%

Naturhouse Health SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-6.11%

EBIT Growth (5y)

-8.51%

EBIT to Interest (avg)

22.81

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.62

Sales to Capital Employed (avg)

2.18

Tax Ratio

27.95%

Dividend Payout Ratio

144.30%

Pledged Shares

Institutional Holding

ROCE (avg)

106.85%

ROE (avg)

60.39%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.97

EV to EBIT

6.03

EV to EBITDA

5.43

EV to Capital Employed

24.94

EV to Sales

1.80

PEG Ratio

0.10

Dividend Yield

785.99%

ROCE (Latest)

413.80%

ROE (Latest)

65.53%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'22 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2022 is -100.00% vs 50.86% in Jun 2021",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2022 is -100.00% vs 300.00% in Jun 2021",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'22",
        "Jun'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "17.50",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "6.80",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.00",
          "val2": "4.80",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "351.70%",
          "chgp": "-35.17%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -3.64% vs -1.98% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 2.02% vs -11.61% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "47.60",
          "val2": "49.40",
          "chgp": "-3.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.40",
          "val2": "15.40",
          "chgp": "-6.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.10",
          "val2": "9.90",
          "chgp": "2.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "279.50%",
          "val2": "272.50%",
          "chgp": "0.70%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'22 - YoY

Jun'22

Jun'21

Change(%)

Net Sales

0.00

17.50

-100.00%

Operating Profit (PBDIT) excl Other Income

0.00

6.80

-100.00%

Interest

0.00

0.10

-100.00%

Exceptional Items

0.00

Consolidate Net Profit

0.00

4.80

-100.00%

Operating Profit Margin (Excl OI)

0.00%

351.70%

-35.17%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2022 is -100.00% vs 50.86% in Jun 2021

Consolidated Net Profit

YoY Growth in quarter ended Jun 2022 is -100.00% vs 300.00% in Jun 2021

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

47.60

49.40

-3.64%

Operating Profit (PBDIT) excl Other Income

14.40

15.40

-6.49%

Interest

0.10

Exceptional Items

0.00

Consolidate Net Profit

10.10

9.90

2.02%

Operating Profit Margin (Excl OI)

279.50%

272.50%

0.70%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -3.64% vs -1.98% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 2.02% vs -11.61% in Dec 2024

All Annual Results

Company CV

About Naturhouse Health SA

Naturhouse Health SA

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available